GSK gets R&D grant that aims to protect U.K. jobs

Economic development officials in the U.K. appear determined to stem the loss of pharma jobs. Scottish Enterprise has awarded a £1.46 million research and development grant to GlaxoSmithKline ($GSK) to support the London-based drug giant's operations in Montrose. The grant is intended to boost research at the site, support the creation of 25 new jobs and protect existing positions. Release

Suggested Articles

Look out, diabetes market: Novo Nordisk won its FDA nod for highly anticipated Rybelsus to control blood sugar in patients with Type 2 diabetes.

Insys is in fire sale mode as part of its bankruptcy plan, and now it’s been given the go-ahead to sell the opioid that helped get it there.

GSK CEO Emma Walmsley could soon have a new title: Microsoft board member. The software giant has nominated her to its board of directors.